Top Health Care Reform Stories
What comes with the new Alzheimer's drug?
By Judith GrahamThe FDA has approved Leqembi, the first disease-modifying treatment for early-stage Alzheimer's and a precursor condition, mild cognitive impairment.
The latest news on health care reform and other regulation and compliance issues that are vital to benefits professionals. Insights and commentary about the latest proposals, and innovative strategies and ideas to ensure you stay focused on helping your customers while the debates rage on in Washington.
The FDA has approved Leqembi, the first disease-modifying treatment for early-stage Alzheimer's and a precursor condition, mild cognitive impairment.